ArticleTranslational andrology and urology2025

Impact of durable response of first-line systemic treatment for patients with locally advanced or metastatic urothelial carcinoma: data update of EV-302/KEYNOTE-A39 trial.

Makito MiyakePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.